Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis

University of Copenhagen Rigshospitalet, Copenhagen

Charite - Campus Virchow-Klinikum, Berlin

Penn State Milton S. Hershey Medical Center, Hershey

Drexel University College of Medicine, Philadelphia

Duke University Health System, Durham

Medical University of South Carolina, Charleston

University of Florida College of Medicine, Gainesville

Central Florida Pulmonary Group, Altamonte Springs

Groupe Hospitalier Pellegrin - Hôpital des Enfants, Bordeaux

Vanderbilt University Medical Center, Nashville

University of Louisville, Louisville

Universiy of Michigan Health System, Ann Arbor

University of Iowa, Iowa City

Mayo Clinic, Rochester

Universitaetsklinikum Frankfurt-Zentrum der Inneren Medizin, Frankfurt

Northwestern University Memorial Hospital, Chicago

University of Kansas Medical Center Research Institute, Inc., Kansas City

Quintiles Overland Park Phase 1 Unit, Overland Park

University of Oklahoma Health Sciences Center, Oklahoma City

Hôpital Cochin, Paris

St. Luke's Cystic Fibrosis Center of Idaho, Boise

Children's Lung Specialists, Las Vegas

Stanford University Medical Center, Stanford

Massachusetts General Hospital, Boston

Childrens Hospital Boston, Boston

St. Paul's Hospital Pacific Lung Research Center, Vancouver

St. Michael's Hospital, Toronto

Institut de Recherches Cliniques de Montreal, Montreal

Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Québec